CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for U.S. Renal Care, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

U.S. Renal Care, Inc.
2400 Dallas Parkway
Suite 350
Phone: 214-736-2700p:214-736-2700 Plano, TX  75093  United States
Business Summary
U.S. Renal Care, Inc. operates as a United States healthcare company which specializes in the providing of hemodialysis, peritoneal dialysis, and kidney disease services to its patients. The Company aims to help its patients travel while on dialysis, work while on dialysis, and also offers diet, nutritional, and exercise solutions.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
---YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--Yes----

Industries
SIC Code Description
8099 Health and allied services, not elsewhere classified

Subsidiaries
Business Name Address City State/Province Country
Dialysis Corporation of America 1302 Concourse Drive Linthicum MD United States


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 8, 2024